Pflanzen als Plattformen für die Herstellung therapeutischer Proteine
摘要
Plant systems are emerging as sustainable platforms for producing recombinant therapeutic proteins. This review highlights the role of the plant secretory pathway – particularly the ER and Golgi – in protein folding and glycosylation. Engineering ER structure and targeting human glycosylation enzymes to specific Golgi compartments enhances protein quality. Plant-based systems offer scalable, low-cost alternatives with improved safety for biopharmaceutical production.